American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia

A Cuker, GM Arepally, BH Chong, DB Cines… - Blood …, 2018 - ashpublications.org
In February 2022, these guidelines were reviewed by an expert work group convened by
ASH. Review included limited searches for new evidence and discussion of the search …

Heparin-induced thrombocytopenia

A Greinacher - New England Journal of Medicine, 2015 - Mass Medical Soc
Key Clinical Points Heparin-Induced Thrombocytopenia Heparin-induced thrombocytopenia
(HIT) is characterized by a decrease in the platelet count of more than 50% from the highest …

Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians …

LA Linkins, AL Dans, LK Moores, R Bona, BL Davidson… - Chest, 2012 - Elsevier
Background Heparin-induced thrombocytopenia (HIT) is an antibody-mediated adverse
drug reaction that can lead to devastating thromboembolic complications, including …

Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians evidence-based clinical practice guidelines

S Schulman, RJ Beyth, C Kearon, MN Levine - Chest, 2008 - Elsevier
This article about hemorrhagic complications of anticoagulant and thrombolytic treatment is
part of the Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians …

Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians evidence-based clinical practice guidelines

TE Warkentin, A Greinacher, A Koster, AM Lincoff - Chest, 2008 - Elsevier
This chapter about the recognition, treatment, and prevention of heparin-induced
thrombocytopenia (HIT) is part of the Antithrombotic and Thrombolytic Therapy: American …

Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

TE Warkentin, A Greinacher - Chest, 2004 - Elsevier
This chapter about the recognition, treatment, and prevention of heparin-induced
thrombocytopenia (HIT) is part of the Seventh ACCP Conference on Antithrombotic and …

Heparin-induced thrombocytopenia: pathogenesis and management.

TE Warkentin - British journal of haematology, 2003 - search.ebscohost.com
Review Page 1 Review HEPARIN-INDUCED THROMBOCYTOPENIA: PATHOGENESIS AND
MANAGEMENT Heparin-induced thrombocytopenia (HIT) is a transient prothrombotic disorder …

Heparin induced thrombocytopenia: diagnosis and management update

I Ahmed, A Majeed, R Powell - Postgraduate medical journal, 2007 - academic.oup.com
Heparin-induced thrombocytopenia (HIT) is a potentially devastating immune mediated
adverse drug reaction caused by the emergence of antibodies that activate platelets in the …

Heparin-induced thrombocytopenia

GM Arepally, TL Ortel - New England Journal of Medicine, 2006 - Mass Medical Soc
A 63-year-old man with coronary artery disease who has recently undergone bypass
surgery presents with dyspnea. Laboratory testing reveals a platelet count of 86,000 per …

Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis

A Greinacher, B Farner, H Kroll… - Thrombosis and …, 2005 - thieme-connect.com
Immune mediated heparin induced thrombocytopenia (HIT) is a prothrombotic adverse effect
of heparin. However, only a subgroup of patients with HIT develops thromboembolic …